Cardiogenic shock complicating acute myocardial infarction in elderly patients: Does admission to a tertiary center improve survival?

American Heart Journal

Volumn 143, Issue 5, 2002, Pages 768-776

  Berger, Alan K ^a,b,c,d   Radford, Martha J ^a,b,c,d   Krumholz, Harlan M ^a,b,c,d  

^a Section of Cardiovascular Medicine   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE NEW HAVEN HOSPITAL   (United States)

^d QUALIDIGM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; COHORT ANALYSIS; CONTROLLED STUDY; ELDERLY CARE; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0036267541     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2002.122289     Document Type: Article

References (45)

1. Cardiogenic shock
2. Cardiogenic shock
3. Trends in cardiogenic shock: Report from the SHOCK study. The should we emergently revascularize occluded coronaries for cardiogenic shock?
4. Current spectrum of cardiogenic shock and effect of early revascularization on mortality: Results of an international registry
5. Early and 1-year survival rates in acute myocardial infarction complicated by cardiogenic shock: A retrospective study comparing coronary angioplasty with medical treatment
6. Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: Incidence, risk factors, and outcome
7. The in-hospital development of cardiogenic shock after myocardial infarction: Incidence, predictors of occurrence, outcome and prognostic factors
8. Risk identification at the time of admission to the coronary unit in patients with suspected myocardial infarction
9. Temporal trends in cardiogenic shock complicating acute myocardial infarction
10. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
11. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
12. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
13. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era
14. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trial
15. Systematic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: In-hospital and long-term survival
16. Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction
17. Percutaneous transluminal coronary angioplasty in patients with cardiogenic shock
18. Cardiogenic shock complicating acute myocardial infarction: The use of coronary angioplasty and the integration of the new support devices into patient management
19. Multicenter registry of angioplasty therapy of cardiogenic shock: Initial and long-term survival
20. Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-1 trial experience
21. Early revascularization in myocardial infarction complicated by cardiogenic shock
22. A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction
23. Should we emergently revascularize occluded coronaries for cardiogenic shock: One-year survival following early revascularization for cardiogenic shock
24. Admission to hospitals with on-site cardiac catheterization facilities
25. The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction
26. Long-term outcome in acute myocardial infarction patients admitted to hospitals with and without on-site cardiac catheterization facilities
27. On-site catheterization laboratory and prognosis after acute myocardial infarction
28. Variation in the use of cardiac procedures after acute myocardial infarction
29. Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada
30. A comparison of management patterns after acute myocardial infarction in Canada and the United States
31. Variation among hospitals in coronary angiography facilities and outcomes after myocardial infarction in a large health maintenance organization
32. Management and outcome of cardiogenic shock complicating acute myocardial infarction in hospitals with and without on-site catheterisation facilities
33. HCFA's Cooperative Cardiovascular Project: A nationwide quality assessment of acute myocardial infarction
34. The health care quality improvement initiative
35. The association between hospital volume and survival after acute myocardial infarction in elderly patients
36. Improving the quality of care for Medicare patients with acute myocardial infarction: Results from the Cooperative Cardiovascular Project
37. Comprehensive reliability assessment and comparison of quality indicators and their components
38. Study outcomes and hospital utilization in the elderly: The advantages of a merged data base for Medicare and Veterans Affairs hospitals
39. The meaning and use of the area under the receiver operating characteristic (ROC) curve
40. Should we emergently revascularize occluded coronaries for cardiogenic shock: An international randomized trial of emergency PTCA/CABG-trial design
41. Usefulness of coronary stenting for cardiogenic shock
42. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review
43. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: A report from the second national registry of myocardial infarction (NRMI-2)